about
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists.Δ(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system.The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells.Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction.Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8.Correction to Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8.Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return.L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib.
P50
Q35783103-F8FFAE28-A757-4AF5-B5E9-751DEBF8E47AQ38835800-E4699D85-E31A-4A71-88B9-6C8B0604D395Q38840809-8FE0B1B1-8FF0-4AE1-A399-C5695D589A3FQ39074330-DFB7DF3A-9F85-474B-AB66-9E7AFAC3E2AAQ47412093-82FAFF60-9738-4C30-8DCC-C6025BF61F0BQ48049925-2036995C-7EE5-48EF-BE36-48D811A8E072Q48284362-3E81FCBF-86B5-414E-BE84-1ABB76E2DE05Q53113265-AC182DE0-CF54-4198-857C-B2EBCC5E06D8Q55410133-B6AA1208-B3F5-495B-A315-243567E2F5E6
P50
description
researcher ORCID ID = 0000-0002-2574-3826
@en
wetenschapper
@nl
name
D Callegari
@ast
D Callegari
@en
D Callegari
@es
D Callegari
@nl
type
label
D Callegari
@ast
D Callegari
@en
D Callegari
@es
D Callegari
@nl
prefLabel
D Callegari
@ast
D Callegari
@en
D Callegari
@es
D Callegari
@nl
P106
P1153
56841555200
P31
P496
0000-0002-2574-3826